In the present study, we conducted a series of in vitro and in vivo assays, aimed to explore the molecular mechanism of miR-148a-3p/Bcl-2 in GC, to lay a theoretical foundation for drug development and possible clinical application in the future. Here, BCL2 is linked to gastric cancer.